GlaxoSmithKline Pharma Receives Rs 222.23 Crore Income Tax Refund for AY 2022-23

GlaxoSmithKline Pharmaceuticals has received a substantial income tax refund amounting to Rs 222.23 crore for the assessment year 2022-23. This refund was issued following the company's tax filings and subsequent reassessment by the Income Tax Department. The pharmaceutical giant had overpaid taxes in its previous financial year, leading to the refund. This development is significant as large corporate tax refunds often highlight discrepancies in the initial tax assessments and can influence corporate cash flow management. The refund also underlines the importance of accurate and efficient tax compliance by multinational corporations like GlaxoSmithKline.